<DOC>
	<DOCNO>NCT00620425</DOCNO>
	<brief_summary>Intraject needle-free , single use , disposable , subcutaneous delivery system pre-filled 6 mg sumatriptan . Healthy Individuals enrol series 3 injection 2 day . Assessment Local Site Signs record 5 day , need .</brief_summary>
	<brief_title>A Study Effects Repeat Doses IntrajectÂ® Sumatriptan Local Site Signs</brief_title>
	<detailed_description>This study evaluate extent , persistence , cumulative effect skin tissue assess local injection site reaction ( bleed , swell , erythema , bruise ) follow repeat administration needle-free Intraject sumatriptan anatomic site .</detailed_description>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>Female subject childbearing potential must agree use acceptable birth control Have abdominal thigh injection site sufficient subcutaneous tissue needlefree injection Fluent speak write English language Provide write informed consent participate study willing comply study procedure Nontobacco user least 12 month prior screen ( type tobacco , include cigar ) A history , symptom , sign ischemic cardiac , cerebrovascular , peripheral vascular syndrome include ischemic vasospastic coronary artery disease Other significant underlie cardiovascular disease include uncontrolled hypertension Hemiplegic basilar migraine A history diagnosis severe hepatic renal impairment A history epilepsy seizure serious neurologic condition A history allergy , anaphylaxis , hypersensitivity sumatriptan component similar drug A history scleroderma ( systemic sclerosis ) skin condition may adversely affect injection absorption subcutaneously administer medication Tattoos , birthmarks significant skin discoloration thigh abdominal area large enough restrict injection site selection and/or evaluation Pregnancy breastfeeding Have participate clinical trial receipt experimental therapy within 30 day prior dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>sumatriptan</keyword>
	<keyword>Intraject</keyword>
	<keyword>Local Site Reactions</keyword>
</DOC>